CAS: 1094428-28-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 4-(Trifluoromethoxy)benzoylformic acid REF: IN-DA01JM4PCAS: 1094428-28-0 | 97% | To inquire | Tue 17 Dec 24 |
 | 2-Oxo-2-(4-(trifluoromethoxy)phenyl)acetic acid REF: 54-PC32906CAS: 1094428-28-0 | - - - | To inquire | Wed 18 Dec 24 |
 | 2-Oxo-2-(4-(trifluoromethoxy)phenyl)acetic acid REF: 10-F738705CAS: 1094428-28-0 | 95% | - - - | Discontinued product |
 | 2-Oxo-2-[4-(trifluoromethoxy)phenyl]acetic acid REF: 3D-UTB42828CAS: 1094428-28-0 | Min. 95% | - - - | Discontinued product |
4-(Trifluoromethoxy)benzoylformic acid
CAS:1094428-28-0
Formula:
C9H5F3O4
Purity:
97%
Molecular weight:
234.1288
Ref: IN-DA01JM4P
| 1g | 499.00 € | ||
| 5g | To inquire | ||
| 250mg | 152.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
2-Oxo-2-(4-(trifluoromethoxy)phenyl)acetic acid
CAS:1094428-28-0
Color and Shape:
Solid
Molecular weight:
234.13g/mol
Ref: 54-PC32906
| Undefined size | To inquire |
Estimated delivery in United States, on Wednesday 18 Dec 2024
2-Oxo-2-(4-(trifluoromethoxy)phenyl)acetic acid
CAS:1094428-28-0
Purity:
95%
Molecular weight:
234.1300048828125
Ref: 10-F738705
| 1g | Discontinued | Request information | |
| 250mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
![2-Oxo-2-[4-(trifluoromethoxy)phenyl]acetic acid](https://static.cymitquimica.com/products/3D/thumb/UTB42828.jpg)
2-Oxo-2-[4-(trifluoromethoxy)phenyl]acetic acid
CAS:1094428-28-0
Please enquire for more information about 2-Oxo-2-[4-(trifluoromethoxy)phenyl]acetic acid including the price, delivery time and more …
Formula:
C9H5F3O4
Purity:
Min. 95%
Molecular weight:
234.13 g/mol
Ref: 3D-UTB42828
| 1g | Discontinued | Request information | |
| 5g | Discontinued | Request information | |
| 10g | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
